Cargando…
Focal Segmental Glomerulosclerosis: Assessing the Risk of Relapse
INTRODUCTION: Kidney outcomes are improved in primary focal segmental glomerulosclerosis (FSGS) by maintaining a remission in proteinuria. However, characteristics associated with relapses are uncertain. We sought to identify these by analyzing each remission. METHODS: We performed a retrospective s...
Autores principales: | Troyanov, Stéphan, Jauhal, Arenn, Reich, Heather N., Hladunewich, Michelle A., Cattran, Daniel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658237/ https://www.ncbi.nlm.nih.gov/pubmed/38025232 http://dx.doi.org/10.1016/j.ekir.2023.08.035 |
Ejemplares similares
-
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis
por: Jauhal, Arenn, et al.
Publicado: (2022) -
Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin
por: Hladunewich, Michelle A., et al.
Publicado: (2021) -
Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis
por: Gipson, Debbie S., et al.
Publicado: (2020) -
Steroid-responsive polyradiculopathy in association with focal segmental glomerulosclerosis
por: Chapman, Andrew R., et al.
Publicado: (2013) -
How Should Pathology Findings Influence Treatment in IgA Nephropathy?
por: Troyanov, Stéphan, et al.
Publicado: (2021)